US Patent Issued to OTTAWA HOSPITAL RESEARCH INSTITUTE on Oct. 14 for "Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,525, issued on Oct. 14, was assigned to OTTAWA HOSPITAL RESEARCH INSTITUTE (Ottawa).

"Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses" was invented by Jean-Simon Diallo (Ottawa), Mohammed Selman (Ann Arbor, Mich.), Rozanne Arulanandam (Orleans, Canada), Nicole Elise Forbes (Ottawa) and Ramya Krishnan (Ottawa).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are fumaric-containing compounds, compositions comprising the same and methods for using such compounds for increasing the capacity of an interferon-sensitive virus to infect, transduce, gr...